Vaccines which have been approved by select regulatory bodies...
VG Somani
Virafin's phase 2 trial has several methodological and reporting...
SputnikĀ V, developed by Moscow's Gamaleya Institute, has proved 91.6%...
The approval could help health authorities minimise vaccine wastage...
Most members of the same group had written a...
Two iterations of the information sheet don't discuss the...
The instruction effectively attempts to tip the scales of...












